Nicole G. Chau

4.9k total citations · 1 hit paper
80 papers, 2.3k citations indexed

About

Nicole G. Chau is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Nicole G. Chau has authored 80 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 29 papers in Surgery and 28 papers in Otorhinolaryngology. Recurrent topics in Nicole G. Chau's work include Head and Neck Cancer Studies (28 papers), Salivary Gland Tumors Diagnosis and Treatment (16 papers) and Ear and Head Tumors (11 papers). Nicole G. Chau is often cited by papers focused on Head and Neck Cancer Studies (28 papers), Salivary Gland Tumors Diagnosis and Treatment (16 papers) and Ear and Head Tumors (11 papers). Nicole G. Chau collaborates with scholars based in United States, Canada and France. Nicole G. Chau's co-authors include Robert I. Haddad, Jonathan D. Schoenfeld, Jochen H. Lorch, Glenn J. Hanna, Roy B. Tishler, Guilherme Rabinowits, Danielle N. Margalit, Vickie Y. Jo, Ravindra Uppaluri and Brandon A. Mahal and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nicole G. Chau

76 papers receiving 2.2k citations

Hit Papers

Management of Salivary Gland Malignancy: ASCO Guideline 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of Salivary Gland Malignancy: ASCO Guideline
    2021 206 citations J.L. Geiger, Nofisat Ismaila et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole G. Chau United States 24 1.3k 798 640 495 449 80 2.3k
Meredith A. Goldwasser United States 17 1.4k 1.1× 558 0.7× 875 1.4× 670 1.4× 969 2.2× 29 2.7k
Paul Swiecicki United States 21 660 0.5× 432 0.5× 540 0.8× 483 1.0× 318 0.7× 96 1.7k
Renzo Corvò Italy 27 931 0.7× 978 1.2× 301 0.5× 1.1k 2.3× 1.1k 2.4× 179 2.8k
Filippo Marino Italy 24 662 0.5× 694 0.9× 304 0.5× 233 0.5× 331 0.7× 121 1.8k
Ammar Sukari United States 24 1.5k 1.2× 311 0.4× 640 1.0× 372 0.8× 635 1.4× 118 2.3k
Caroline Even France 22 1.8k 1.4× 692 0.9× 332 0.5× 853 1.7× 812 1.8× 142 2.5k
Jared Weiss United States 24 1.1k 0.8× 630 0.8× 430 0.7× 730 1.5× 1.1k 2.4× 104 2.2k
Shubhada Kane India 26 1.1k 0.9× 1.1k 1.3× 463 0.7× 1.1k 2.1× 390 0.9× 104 2.6k
Giovanni Franchin Italy 25 646 0.5× 531 0.7× 234 0.4× 760 1.5× 852 1.9× 109 2.0k
Silke Tribius Germany 27 773 0.6× 861 1.1× 351 0.5× 882 1.8× 490 1.1× 83 2.1k

Countries citing papers authored by Nicole G. Chau

Since Specialization
Citations

This map shows the geographic impact of Nicole G. Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole G. Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole G. Chau more than expected).

Fields of papers citing papers by Nicole G. Chau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole G. Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole G. Chau. The network helps show where Nicole G. Chau may publish in the future.

Co-authorship network of co-authors of Nicole G. Chau

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole G. Chau. A scholar is included among the top collaborators of Nicole G. Chau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole G. Chau. Nicole G. Chau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezzat, Shereen, Jesse D. Pasternak, Murali Rajaraman, et al.. (2024). Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma. Frontiers in Oncology. 14. 1437360–1437360. 3 indexed citations
2.
Mete, Özgür, Andrée Boucher, Kasmintan A. Schrader, et al.. (2024). Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocrine Pathology. 35(4). 293–308. 16 indexed citations
3.
Barletta, Justine A., Michelle Afkhami, Diana Bell, et al.. (2022). NUTM1-rearranged Carcinoma of the Thyroid. The American Journal of Surgical Pathology. 46(12). 1706–1715. 12 indexed citations
4.
Geiger, J.L., Nofisat Ismaila, Beth M. Beadle, et al.. (2021). Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology. 39(17). 1909–1941. 206 indexed citations breakdown →
5.
Ahmadi, Sara, et al.. (2021). Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas. Histopathology. 79(3). 427–436. 13 indexed citations
6.
Hanna, Glenn J., Jochen H. Lorch, Robert I. Haddad, et al.. (2020). The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers. The Oncologist. 25(7). 598–608. 29 indexed citations
7.
Guenette, Jeffrey P., Nicole G. Chau, Cyrus Sayehli, et al.. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer. 126(17). 3972–3981. 37 indexed citations
8.
Chau, Nicole G., Clement Ma, Hasan Al‐Sayegh, et al.. (2019). An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients. JNCI Cancer Spectrum. 4(2). pkz094–pkz094. 131 indexed citations
9.
Kim, Daniel W., Grace Lee, Miranda B. Lam, et al.. (2019). Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the Literature. Advances in Radiation Oncology. 5(2). 301–310. 5 indexed citations
10.
Mandelbaum, Joseph, Ilya Shestopalov, Rachel E. Henderson, et al.. (2018). Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. The Journal of Experimental Medicine. 215(10). 2673–2685. 53 indexed citations
11.
Chau, Nicole G., Yvonne Y. Li, Vickie Y. Jo, et al.. (2016). Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 22(12). 2939–2949. 39 indexed citations
12.
Sridharan, Vishwajith, Evisa Gjini, Xiaoyun Liao, et al.. (2016). Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunology Research. 4(8). 679–687. 77 indexed citations
13.
Abramson, Vandana G., Jeffrey G. Supko, Tarah J. Ballinger, et al.. (2016). Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors. Clinical Cancer Research. 23(14). 3520–3528. 23 indexed citations
14.
Raldow, Ann C., Nicole G. Chau, Matthew S. Davids, et al.. (2015). Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple. BJR|case reports. 2(1). 20150271–20150271. 4 indexed citations
15.
Shapiro, Geoffrey I., James W. Mier, John Hilton, et al.. (2015). A phase 1, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). TPS2613–TPS2613. 2 indexed citations
16.
17.
18.
Chau, Nicole G., Bayardo Perez‐Ordoñez, Katherine Zhang, et al.. (2011). The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head & Neck Oncology. 3(1). 11–11. 62 indexed citations
19.
Chau, Nicole G., Edward S. Kim, & Ignacio Wistuba. (2010). The Multidisciplinary Approach to Thymoma: Combining Molecular and Clinical Approaches. Journal of Thoracic Oncology. 5(10). S313–S317. 9 indexed citations
20.
Chau, Nicole G., Camilla Zimmermann, Clement Ma, Nathan Taback, & Monika K. Krzyzanowska. (2009). Bereavement Practices of Physicians in Oncology and Palliative Care. Archives of Internal Medicine. 169(10). 963–963. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meredith A. Goldwasser Breakdown of academic impact, for papers by Paul Swiecicki Breakdown of academic impact, for papers by Renzo Corvò Breakdown of academic impact, for papers by Filippo Marino Breakdown of academic impact, for papers by Ammar Sukari Breakdown of academic impact, for papers by Caroline Even Breakdown of academic impact, for papers by Jared Weiss Breakdown of academic impact, for papers by Shubhada Kane Breakdown of academic impact, for papers by Giovanni Franchin Breakdown of academic impact, for papers by Silke Tribius
Rankless by CCL
2026